Key Takeaways Robinhood’s stock reached an all-time high driven by strong speculation of its imminent inclusion in the S&P 500 index. Inclusion would trigger mandatory purchases from index-tracking funds, with...
Key Takeaways Ethereum has surpassed the $4,000 resistance level, a move supported by strong on-chain activity, rising network fees, and a significant portion of its supply being staked. Institutional sentiment...
Key Takeaways Alphabet’s stock price has surpassed the psychological $200 threshold, a significant technical milestone after facing repeated resistance at this level in previous months. The stock is trading at...
Key Takeaways The rollout of AMD’s MI350X accelerator in Q3 2025 is a critical catalyst, with analysts projecting it could add over $5 billion to data centre revenue by fiscal...
Key Takeaways Tempus AI surpassed Q2 2025 analyst expectations, reporting sales of $315 million against a forecast of $297 million and an improved adjusted EPS of -$0.22. The genomics division...
Key Takeaways Valuing health insurers like Oscar Health using total cash is misleading, as these funds are largely regulatory reserves earmarked for future claims, not discretionary capital. The price-to-book (P/B)...
Key Takeaways Technological De-risking: Successful 4G and 5G satellite-to-phone tests and progress with the BlueBird constellation have transformed engineering speculation into tangible, confidence-building milestones. Strengthened Financial Position: Over $1 billion...
Key Takeaways Nebius Group’s stock surged by a remarkable 180% after an in-depth analysis brought its potential as an under-the-radar AI infrastructure provider to light. The rally was significantly fuelled...
Key Takeaways In the second quarter of 2025, elite investors made UnitedHealth Group (UNH) their top acquisition by volume, treating its significant share price decline as a deep value opportunity....
Key Takeaways Eli Lilly’s oral obesity drug, orforglipron, demonstrated a ~12.4% weight loss in its Phase 3 trial, a clinically significant result that nonetheless fell short of high investor expectations....
